Premium
A Pilot Study to Measure Cognitive Efficiency During Migraine
Author(s) -
Farmer Kathleen,
Cady Roger,
Bleiberg Joseph,
Reeves Dennis
Publication year - 2000
Publication title -
headache: the journal of head and face pain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.14
H-Index - 119
eISSN - 1526-4610
pISSN - 0017-8748
DOI - 10.1046/j.1526-4610.2000.040008657.x
Subject(s) - migraine , sumatriptan , medicine , cognition , neuropsychology , migraine treatment , physical therapy , anesthesia , effects of sleep deprivation on cognitive performance , agonist , psychiatry , receptor
Background and Objectives.—The measurement of cognitive efficiency during migraine has produced conflicting results primarily due to the types of tests used. The objectives of this pilot study were two‐fold: to measure cognitive efficiency during migraine, compared to a migraine‐free period, and to evaluate the effects of therapy with a 5‐HT 1 agonist (sumatriptan injection, 6 mg) on the cognitive efficiency of migraineurs during a migraine. Method.—The Headache Care Center‐Automated Neuropsychological Assessment Metrics was administered to 10 migraineurs, three times without a migraine, once during a migraine, and three times after administration of sumatriptan injection (6 mg). Results.—The results demonstrated a significant drop in cognitive efficiency during migraine and recovery 15 minutes after therapeutic injection. Conclusions.—This pilot study is the first to document a significant drop in cognitive functioning during migraine and recovery after administration of a migraine‐specific medication.